

Get the latest on the Betaxolol shortage in 2026. Learn what's causing it, which formulations are affected, and what patients can do.
The Betaxolol shortage has been an evolving situation, and as of early 2026, patients continue to face challenges finding this medication. Whether you use Betaxolol tablets for hypertension or Betaxolol eye drops for glaucoma, this update covers the current state of the shortage and what it means for you.
The Betaxolol oral tablet shortage began when Epic Pharma discontinued its production of generic Betaxolol tablets. The brand-name version, Kerlone, was discontinued in the U.S. years earlier. With fewer manufacturers producing the oral form, supply has been inconsistent. Some pharmacies may be able to source Betaxolol tablets through secondary wholesalers, but availability varies significantly by region.
The FDA has listed Betaxolol tablets on its drug shortage database, and the situation is being monitored. However, no firm resolution date has been announced.
The ophthalmic situation is more complex:
Betaxolol shortages are driven by a combination of factors that affect many older generic medications:
For a deeper dive into these factors, read our article on why Betaxolol is so hard to find.
Betaxolol stock levels change frequently. Use MedFinder to monitor pharmacy availability in your area. When you find it, consider asking your doctor for a 90-day prescription to reduce the frequency of your search.
Start looking for your refill at least two weeks before your current supply runs out. This gives you time to search multiple pharmacies or explore alternatives if needed.
Talk to your prescriber now—before you run out—about what alternative medication you could switch to if Betaxolol becomes completely unavailable. Having a backup prescription ready can save you from a gap in treatment. See our guide on Betaxolol alternatives.
You can help by reporting drug shortages to the FDA. Patient reports help the FDA prioritize which shortages to address and can encourage manufacturers to increase production.
Unfortunately, there's no clear end date for the Betaxolol shortage. For the oral formulation, the shortage may improve if remaining manufacturers increase production or new generic companies enter the market. For Betoptic S specifically, the discontinuation is permanent.
The FDA continues to work with manufacturers to resolve drug shortages, but older generic medications with small markets are often the last to see relief.
We'll continue to update this page as the Betaxolol shortage situation evolves. Bookmark this page and check back for the latest information. In the meantime, use MedFinder to stay ahead of supply issues and find Betaxolol when it's available.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.